SRXN1 and neoplasm: Actually, Dr. Wei demonstrated that the Srx-Prx4 axis is required for sufficient activation of MAPK pathway, and suggested that Srx-Prx4 promoted tumor progression through the regulation of the MAPK pathway when our lab first identified this antioxidant axis and its critical role in human cancer maintenance and metastasis [24].